News

Palatin has also earned a milestone payment of $2.5 million in connection with its collaboration and licensing agreement with AstraZeneca. Palatin anticipates receiving the $2.5 million in the

Most recently, Mr Shrewsbury served as chief medical officer and senior vice president of clinical development and regulatory affairs at Adamas Pharmaceuticals. Prior to that, Mr Shrewsbury served

Based on the outcome of the study, Guided Therapeutics (GT) plans to submit the trial results to the FDA as part of the premarket approval (PMA) application for

The Phase I clinical trial is designed to assess the safety, tolerability and pharmacokinetics of IB1001 in patients with hemophilia B, compared with the commercially available recombinant Factor

Mr Altmeyer succeeds interim president and CEO of Otsuka America Pharmaceutical, Dean Haubrich, who has been leading the company since August 1, 2008 and has been named chairman

According to the company, the ViralClyns P95 respirator has shown to be 100 times more effective than other respirators in its class, stopping 99.99% of airborne and droplet

Under the terms of the agreement, Merck, through an affiliate, will pay Insmed $130 million in cash to acquire all rights to the Boulder facilities and Insmed’s pipeline

The Celerus Wave System is said to be the first and only solution to deliver precise, standardized histology and cytology results in 15 minutes. Intra-operative frozen tissue sections

Mr Joubert is currently a founding partner of EdgeAdvisors, a privately held management consulting organization, and a director of Stream Global Services, a provider of multi-shore business process